Allgens Medical Technology Inc. logo

Allgens Medical Technology Inc. (688613)

Market Closed
6 Aug, 06:57
SSE SSE
¥
15. 01
0
0%
¥
2.28B Market Cap
- P/E Ratio
0.24% Div Yield
2.03M Volume
- Eps
¥ 15.01
Previous Close
Add Transaction
Day Range
14.7 15.19
Year Range
12.94 29.88
Want to track 688613 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688613 closed today higher at ¥15.01, an increase of 0% from yesterday's close, completing a monthly increase of 7.2143% or ¥1.01. Over the past 12 months, 688613 stock lost -26.7448%.
688613 pays dividends to its shareholders, with the most recent payment made on 22 hours ago. The next payment will be today for a total of ¥0.0304.
The last earnings report, released on Apr 25, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688613 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.1
-1.7279%
Shinva Medical Instrument Co., Ltd.
¥ 12.72
-1.3953%
Inventisbio Co., Ltd.
¥ 19.01
-1.0411%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 18.87
-0.4222%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 11.95
+0.4202%

Allgens Medical Technology Inc. (688613) FAQ

What is the stock price today?

The current price is ¥15.01.

On which exchange is it traded?

Allgens Medical Technology Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688613.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.24%.

What is its market cap?

As of today, the market cap is 2.28B.

Has Allgens Medical Technology Inc. ever had a stock split?

No, there has never been a stock split.

Allgens Medical Technology Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Menglong Cui CEO
SSE Exchange
CNE1000051W7 ISIN
CN Country
202 Employees
6 Aug 2026 Last Dividend
- Last Split
- IPO Date

Overview

Allgens Medical Technology CO., LTD. is a prominent company in the biomedicine sector, focusing on the innovative development, manufacturing, and commercialization of biomedical materials and medical device products primarily within the Chinese market. With a foundation year of 2004 and a base in Beijing, China, Allgens has carved its niche by offering high-quality solutions aimed at addressing critical needs within the medical field. Their expertise lies broadly in creating products that facilitate bone repair and regeneration, catering to various medical specialties such as orthopedics, oral surgery, plastic surgery, and neurosurgery. By distributing their products to agents and terminal hospitals, they ensure that their state-of-the-art medical solutions are accessible to a wide range of healthcare providers.

Products and Services

The product portfolio of Allgens Medical Technology showcases a sophisticated range of biomedical materials designed for diverse applications across several medical specialties. Each product reflects the company’s commitment to innovation, quality, and patient care.

  • Igium Gold: This product stands out in the treatment of bone defect repair within the orthopaedics domain. Utilizing cutting-edge technology, Igium Gold provides a reliable and effective solution for patients requiring bone regeneration, thereby enhancing recovery and improving clinical outcomes.
  • Tooth Shell: Specifically designed for oral or plastic surgery contexts, the Tooth Shell represents a breakthrough in treatments associated with dental and facial reconstructive procedures. This product exemplifies the integration of biomedical technology with aesthetic recovery, offering patients both functional and cosmetic benefits.
  • Turui: Turui is tailored for the neurosurgery field, where precision and reliability are paramount. This product addresses challenging conditions requiring neurosurgical intervention, such as the treatment of brain or spine-related defects, thereby standing at the forefront of neurosurgical advancements.
  • BonGold: Another jewel in the crown for orthopedic applications, BonGold is dedicated to the effective treatment of orthopedic bone defects. Similar to Igium Gold, it underscores Allgens Medical’s expertise in bone repair materials but is distinctively formulated to cater to specific orthopedic needs, showcasing the company’s capacity to innovate within tightly defined medical specialties.

Contact Information

Address: No. 5 Kaikai Road, Beijing, China, 100026
Phone: 86 10 5633 0938